Cline Scientific Investor Relations Material

Cline Scientific AB develops advanced cancer diagnostics and regenerative medicine treatments using its unique patented surface nanotechnology. This technology addresses critical challenges in cell-based products and processes within the life sciences. The company is actively working on two major projects: StemCART, a stem cell therapy for joint repair, and CellRACE, a cancer diagnostic tool aimed at predicting metastasis. These innovations are developed in collaboration with pharmaceutical companies and academic researchers worldwide. The company is headquartered in Mölndal, Västra Götalands län, Sweden, and its shares are listed on the Stockholm Stock Exchange.